Literature DB >> 24602570

The transdermal inhibition of melanogenesis by a cell-membrane-permeable peptide delivery system based on poly-arginine.

Nanako Ookubo1, Hiroyuki Michiue2, Mizuki Kitamatsu3, Maho Kamamura1, Tei-ichi Nishiki1, Iori Ohmori1, Hideki Matsui1.   

Abstract

Topical therapy is the most favored form of treatment for whitening against hyper-pigmentation and sunburn because it lends itself to self-administration, patient compliance and an absence of systemic adverse effects. However, high-molecular-weight, hydrophilic chemicals are difficult to use as transdermal delivery drugs and the use of topical drugs has been highly limited. There are now many potent tyrosinase inhibitors, for example, sulfite or kojic acid, but the efficacy of their skin transduction remains a big problem. Furthermore, melanogenesis inhibitors from natural sources have great potential, as they are considered to be safe and largely free from adverse side effects. We applied 11-arginine (11R), a cell-membrane-permeable peptide, as a transdermal delivery system with a skin delivery enhancer, pyrenbutyrate. We performed intracellular screening for melanogenesis inhibitors with 11R fused with several kinds of tyrosinase inhibitory peptides from natural sources. Of 28 tyrosinase peptides, 13 melanin synthesis inhibitory peptides were selected. Peptide No. 10 found in gliadin protein, a wheat component, most strongly inhibited melanin production. This No. 10 peptide, of only 8 amino acids, fused to 11R showed no cytotoxicity and inhibited melanin synthesis as determined through melanin content measured using an absorption spectrometer and observation with a transmission electron microscope. Next, we transduced this 11R-No. 10 into skin with an 11R transdermal delivery system after previous treatment with pyrenbutyrate and performed daily repetitive topical application for two weeks against a UV-induced sun-tanning guinea pig model. We observed a whitening effect in a model skin sample by Masson-Fontana staining and the 11R-No. 10 peptide-applied area showed significant melanogenesis inhibition. These results show that 11R using a transdermal drug delivery system with melanogenesis inhibitory peptide is a very safe and promising method for applications from cosmetics to the pharmaceutical industry.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  11R; CPP; Melanin; Melanogenesis; TAT; Transdermal drug delivery system

Mesh:

Substances:

Year:  2014        PMID: 24602570     DOI: 10.1016/j.biomaterials.2014.01.052

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  9 in total

1.  Behaviour of four different B16 murine melanoma cell sublines: C57BL/6J skin.

Authors:  Corina Danciu; Camelia Oprean; Dorina E Coricovac; Cioca Andreea; Anca Cimpean; Heinfried Radeke; Codruta Soica; Cristina Dehelean
Journal:  Int J Exp Pathol       Date:  2015-02-09       Impact factor: 1.925

2.  Cell penetrating peptides as efficient nanocarriers for delivery of antifungal compound, natamycin for the treatment of fungal keratitis.

Authors:  Aastha Jain; Sushmita G Shah; Archana Chugh
Journal:  Pharm Res       Date:  2014-12-03       Impact factor: 4.200

Review 3.  Cell-Penetrating Peptides as Passive Permeation Enhancers for Transdermal Drug Delivery.

Authors:  Lipika Chablani; Vijay Singh
Journal:  AAPS PharmSciTech       Date:  2022-09-26       Impact factor: 4.026

Review 4.  The Hypopigmentation Mechanism of Tyrosinase Inhibitory Peptides Derived from Food Proteins: An Overview.

Authors:  Yuqiong Song; Shengjun Chen; Laihao Li; Yaoxun Zeng; Xiao Hu
Journal:  Molecules       Date:  2022-04-22       Impact factor: 4.927

5.  TYR as a multifunctional reporter gene regulated by the Tet-on system for multimodality imaging: an in vitro study.

Authors:  Hongyan Feng; Xiaotian Xia; Chongjiao Li; Yiling Song; Chunxia Qin; Yongxue Zhang; Xiaoli Lan
Journal:  Sci Rep       Date:  2015-10-20       Impact factor: 4.379

Review 6.  Fermented broth in tyrosinase- and melanogenesis inhibition.

Authors:  Chin-Feng Chan; Ching-Cheng Huang; Ming-Yuan Lee; Yung-Sheng Lin
Journal:  Molecules       Date:  2014-08-26       Impact factor: 4.411

7.  Topical anesthetic and pain relief using penetration enhancer and transcriptional transactivator peptide multi-decorated nanostructured lipid carriers.

Authors:  Tao Jiang; Shuangshuang Ma; Yangyang Shen; Yuwen Li; Ruirui Pan; Huaixin Xing
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

8.  Targeting delivery and minimizing epidermal diffusion of tranexamic acid by hyaluronic acid-coated liposome nanogels for topical hyperpigmentation treatment.

Authors:  Ying Liu; Yue Han; Tingting Zhu; Xianglei Wu; Wenxin Yu; Jiafang Zhu; Ying Shang; Xiaoxi Lin; Tianlan Zhao
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

9.  Dexmedetomidine and levobupivacaine co-loaded, transcriptional transactivator peptide modified nanostructured lipid carriers or lipid-polymer hybrid nanoparticles, which performed better for local anesthetic therapy?

Authors:  Min Li; Shuo Feng; Huaixin Xing; Yingui Sun
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.